Ligand validation:7QLP

TBE: TAZOBACTAM INTERMEDIATE

TBE is a Ligand Of Interest in 7QLP designated by the Author

	Best-fitted instance in this entry
	Other instances in this entry

	Best-fitted instance in this entry
	Best-fitted PDB instances with same target (top 5)

	Best-fitted instance in this entry
	Best-fitted PDB instances with different target (top 5)

Identifier	Ranking for goodness of fit	Ranking for geometry	Real space R factor	Real space correlation coefficient	RMSZ-bond-length	RMSZ-bond-angle	Outliers of bond length	Outliers of bond angle	Atomic clashes	Stereochemical errors	Model completeness	Average occupancy
7QLP_TBE_D_301	38%	40%	0.172	0.874	1.18	1.21	2	1	1	0	100%	0.7
7QLP_TBE_C_301	31%	39%	0.18	0.847	1.38	1.06	3	1	0	0	100%	0.7
7QLP_TBE_A_301	27%	34%	0.205	0.852	1.24	1.46	2	1	0	0	100%	0.7
7QLP_TBE_E_301	4%	24%	0.311	0.698	1.52	1.74	3	2	0	0	100%	0.7
7QNK_TBE_C_301	38%	41%	0.191	0.893	1.32	1.02	2	1	1	0	100%	0.7
3NIA_TBE_A_288	86%	19%	0.088	0.957	2.84	0.84	3	-	0	0	100%	0.9715
6XFS_TBE_A_501	53%	41%	0.139	0.902	1.46	0.88	3	-	0	0	100%	1
4A5R_TBE_A_1292	49%	15%	0.167	0.916	2.87	1.13	3	1	0	0	100%	1
1TDG_TBE_A_701	42%	0%	0.157	0.878	14.36	20.53	7	4	1	0	100%	0.33
6H2I_TBE_B_501	40%	9%	0.191	0.904	2.94	1.74	4	2	0	0	100%	1

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM133198.